Login / Signup

Microbiota in the Natural History of Pancreatic Cancer: From Predisposition to Therapy.

Cecilia BindaGiulia GibiinoMonica SbranciaChiara ColuccioMaria CazzatoLorenzo CarloniAlessandro CucchettiGiorgio ErcolaniVittorio SambriCarlo Fabbri
Published in: Cancers (2022)
Early microbiome insights came from gut microbes and their role among intestinal and extraintestinal disease. The latest evidence suggests that the microbiota is a true organ, capable of several interactions throughout the digestive system, attracting specific interest in the biliopancreatic district. Despite advances in diagnostics over the last few decades and improvements in the management of this disease, pancreatic cancer is still a common cause of cancer death. Microbiota can influence the development of precancerous disease predisposing to pancreatic cancer (PC). At the same time, neoplastic tissue shows specific characteristics in terms of diversity and phenotype, determining the short- and long-term prognosis. Considering the above information, a role for microbiota has also been hypothesized in the different phases of the PC approach, providing future revolutionary therapeutic insights. Microbiota-modulating therapies could open new issues in the therapeutic landscape. The aim of this narrative review is to assess the most updated evidence on microbiome in all the steps regarding pancreatic adenocarcinoma, from early development to response to antineoplastic therapy and long-term prognosis.
Keyphrases
  • stem cells
  • signaling pathway
  • squamous cell carcinoma
  • papillary thyroid
  • squamous cell
  • mesenchymal stem cells
  • health information
  • single cell
  • weight loss